That means companies such as Lilly, Novo Nordisk, Sanofi and AstraZeneca will soon ... management system combines a connected insulin pen with glucose-sensing technologies (e.g., glucose meter ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% ...

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...

With Wegovy now playing catch-up and CagriSema failing to shake up the game, Novo is staring down a serious challenge from Lilly, which is running away with the weight-loss drug crown. So ...

What do Trump's tariffs have to do with Eli Lilly? Novo Nordisk (NYSE: NVO) is based in Denmark, which is one of the countries on Trump's list for especially high tariffs. Novo Nordisk's type 2 ...

Trump has threatened to impose "very high" tariffs on Denmark if it doesn't sell Greenland to the U.S. These tariffs could cause the prices of Novo Nordisk's diabetes and obesity drugs to increase.